Inventor
GUERLAVAIS VINCENT
US24 patents
⚠️ This page may combine multiple inventors who share the name “GUERLAVAIS VINCENT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AILERON THERAPEUTICS INC
15 patentsUS8927500B2Jan 6, 2015
Peptidomimetic macrocycles
AILERON THERAPEUTICS INC44 citations96
US9957299B2May 1, 2018
Peptidomimetic macrocycles
AILERON THERAPEUTICS INC14 citations92
US9522947B2Dec 20, 2016
Peptidomimetic macrocycles
AILERON THERAPEUTICS INC25 citations92
US9096684B2Aug 4, 2015
Peptidomimetic macrocycles
AILERON THERAPEUTICS INC28 citations92
US8987414B2Mar 24, 2015
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
AILERON THERAPEUTICS INC30 citations90
US10023613B2Jul 17, 2018
Peptidomimetic macrocycles as modulators of MCL-1
AILERON THERAPEUTICS INC17 citations85
US10059741B2Aug 28, 2018
Peptidomimetic macrocycles
AILERON THERAPEUTICS INC10 citations83
US10967042B2Apr 6, 2021
Peptidomimetic macrocycles
AILERON THERAPEUTICS INC1 citations71
US10308699B2Jun 4, 2019
Peptidomimetic macrocycles
AILERON THERAPEUTICS INC1 citations71
US10213477B2Feb 26, 2019
Peptidomimetic macrocycles
AILERON THERAPEUTICS INC2 citations71
US10227380B2Mar 12, 2019
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
AILERON THERAPEUTICS INC2 citations69
US11008366B2May 18, 2021
Peptidomimetic macrocycles
AILERON THERAPEUTICS INC0 citations62
US10246491B2Apr 2, 2019
Peptidomimetic macrocycles and use thereof in regulating HIF1alpha
AILERON THERAPEUTICS INC1 citations62
US10703780B2Jul 7, 2020
Peptidomimetic macrocycles
AILERON THERAPEUTICS INC0 citations52
US11091522B2Aug 17, 2021
Peptidomimetic macrocycles and uses thereof
AILERON THERAPEUTICS INC0 citations49